BioLife Solutions (BLFS) Competitors $22.81 -0.13 (-0.57%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLFS vs. IRTC, BLCO, TMDX, SLNO, NVST, PRCT, LIVN, ENOV, NVCR, and WRBYShould you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. BioLife Solutions vs. iRhythm Technologies Bausch + Lomb TransMedics Group Soleno Therapeutics Envista PROCEPT BioRobotics LivaNova Enovis NovoCure Warby Parker BioLife Solutions (NASDAQ:BLFS) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation, dividends and community ranking. Which has higher earnings & valuation, BLFS or IRTC? BioLife Solutions has higher earnings, but lower revenue than iRhythm Technologies. BioLife Solutions is trading at a lower price-to-earnings ratio than iRhythm Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$87.76M12.35-$66.43M-$0.29-78.66iRhythm Technologies$618.59M7.29-$123.41M-$3.14-44.97 Is BLFS or IRTC more profitable? iRhythm Technologies has a net margin of -19.14% compared to BioLife Solutions' net margin of -38.98%. BioLife Solutions' return on equity of -6.61% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-38.98% -6.61% -5.54% iRhythm Technologies -19.14%-118.83%-11.34% Do insiders and institutionals hold more shares of BLFS or IRTC? 93.2% of BioLife Solutions shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by insiders. Comparatively, 1.1% of iRhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community favor BLFS or IRTC? iRhythm Technologies received 100 more outperform votes than BioLife Solutions when rated by MarketBeat users. However, 66.74% of users gave BioLife Solutions an outperform vote while only 66.19% of users gave iRhythm Technologies an outperform vote. CompanyUnderperformOutperformBioLife SolutionsOutperform Votes31366.74% Underperform Votes15633.26% iRhythm TechnologiesOutperform Votes41366.19% Underperform Votes21133.81% Which has more volatility & risk, BLFS or IRTC? BioLife Solutions has a beta of 2.01, meaning that its share price is 101% more volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Does the media favor BLFS or IRTC? In the previous week, BioLife Solutions had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 10 mentions for BioLife Solutions and 8 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.48 beat BioLife Solutions' score of 1.13 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate BLFS or IRTC? BioLife Solutions presently has a consensus price target of $31.17, suggesting a potential upside of 36.64%. iRhythm Technologies has a consensus price target of $128.55, suggesting a potential downside of 8.97%. Given BioLife Solutions' stronger consensus rating and higher possible upside, research analysts plainly believe BioLife Solutions is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.91 SummaryBioLife Solutions beats iRhythm Technologies on 13 of the 18 factors compared between the two stocks. Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLFS vs. The Competition Export to ExcelMetricBioLife SolutionsElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.08B$3.34B$5.43B$8.48BDividend YieldN/A1.73%5.22%4.11%P/E Ratio-21.5217.5026.8220.05Price / Sales12.3582.07393.28116.44Price / CashN/A44.0938.2534.62Price / Book2.973.866.874.61Net Income-$66.43M$94.03M$3.22B$248.19M7 Day Performance3.45%6.65%6.81%2.97%1 Month Performance7.85%30.40%13.71%16.58%1 Year Performance5.21%-9.55%18.30%8.16% BioLife Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLFSBioLife Solutions2.4743 of 5 stars$22.81-0.6%$31.17+36.6%+4.5%$1.08B$87.76M-21.52440News CoveragePositive NewsAnalyst DowngradeIRTCiRhythm Technologies1.3027 of 5 stars$137.80+0.1%$128.55-6.7%+52.5%$4.40B$618.59M-37.861,790Positive NewsBLCOBausch + Lomb4.3015 of 5 stars$11.91+5.6%$15.50+30.2%-19.2%$4.21B$4.83B-13.0812,500Gap UpTMDXTransMedics Group1.4365 of 5 stars$118.73+6.5%$126.70+6.7%-10.0%$4.02B$488.23M126.31210Positive NewsSLNOSoleno Therapeutics4.8655 of 5 stars$76.70-0.1%$106.78+39.2%+59.6%$3.87BN/A-23.1030News CoveragePositive NewsNVSTEnvista4.0514 of 5 stars$18.56+5.5%$20.08+8.2%-2.7%$3.15B$2.50B-2.8612,700Positive NewsGap UpPRCTPROCEPT BioRobotics2.9744 of 5 stars$54.44+2.5%$90.00+65.3%-13.9%$3.01B$249.12M-27.92430Positive NewsGap UpLIVNLivaNova3.8534 of 5 stars$45.23+2.7%$59.17+30.8%-26.8%$2.47B$1.28B107.692,900Positive NewsAnalyst UpgradeGap UpHigh Trading VolumeENOVEnovis3.2393 of 5 stars$36.67+11.0%$55.00+50.0%-32.6%$2.09B$2.15B-16.746,800High Trading VolumeNVCRNovoCure3.6511 of 5 stars$18.57+6.8%$32.83+76.8%-24.3%$2.07B$621.71M-13.261,320Positive NewsGap UpWRBYWarby Parker2.2173 of 5 stars$18.88+19.9%$22.21+17.6%+22.3%$1.97B$795.09M-69.943,030Trending NewsHigh Trading Volume Related Companies and Tools Related Companies iRhythm Technologies Competitors Bausch + Lomb Competitors TransMedics Group Competitors Soleno Therapeutics Competitors Envista Competitors PROCEPT BioRobotics Competitors LivaNova Competitors Enovis Competitors NovoCure Competitors Warby Parker Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLFS) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BLFS Stock Free BLFS Stock Alerts